dc.contributor.author |
Lizarzaburu-Robles, JC |
|
dc.contributor.author |
Garro-Mendiola, A |
|
dc.contributor.author |
Lazo Porras, María de los Ángeles |
|
dc.contributor.author |
Vento, F |
|
dc.contributor.author |
Lorenzo, O |
|
dc.date.accessioned |
2023-09-06T20:45:07Z |
|
dc.date.available |
2023-09-06T20:45:07Z |
|
dc.date.issued |
2023 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/14051 |
|
dc.description.abstract |
Background: Early detection of subjects at risk for type 2 diabetes (T2DM) is critical to prevent or delay cardiometabolic complications. 1-Hour Post-Load Glucose(1h-PG) ≥155mg/dL, the Metabolic Syndrome (MS) and FINDRISC (FR) score need more studies to predict T2DM in individuals with normal glucose tolerance (NGT), in Latin American population. Aim: To evaluate 1h-PG≥155mg/dL, MS and FR scores in patients with impaired fasting glucose (IFG) to predict T2D at seven years (7yrs). Methodology: 218 consecutive subjects with IFG performed an oral glucose tolerant test (OGTT) and were followed-up for 7yrs. The outcome was diagnosis of T2DM, and the exposures were 1h-PG≥155mg/dL, MS and FR scores (≥13points) following the criteria of the Latin-American Diabetes-Association. Frequencies were described and the association between T2DM diagnosis with the exposures were explored using chi2 test. Relative risk (RR) was estimated using Poisson regression with 95%CIs. Results: The mean age was 56.2 ±11.5 years-old, and 64.0% of them were female. 63.8% were overweigh/obese. 66.8% had MS, 64.3% FR ≥13points, and 46.8% exhibited 1h-PG ≥155mg/dL. After 7yrs of follow-up, 21.1% developed T2DM, but only 25.2% and 20% of them had MS (p=0.049) and FR ≥13points (p=0.258) respectively. 33.3% exhibited 1h-PG ≥155mg/dL (p<0.001). When evaluating the association of T2DM with MS, FR ≥13points or 1h-PG ≥155mg/dL with NGT, the RR adjusting by gender and age were 2.07 (1.07–4.00; 95%CI), 1.42 (0.64-3.19; 95%CI) and 3.85 (1.97-7.52; 95%CI) respectively. Conclusion: 1h-PG ≥155mg/dL may predict T2DM better than the MS in individuals with IGF. Furthers analysis were required for FR. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
Metabolism-Clinical and Experimental |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Oral Glucose tolerance test |
en_US |
dc.subject |
Metabolic Syndrome |
en_US |
dc.subject |
FINDRISC |
en_US |
dc.subject |
1hr Post load Glucose |
en_US |
dc.subject.mesh |
Prueba de Tolerancia a la Glucosa |
|
dc.subject.mesh |
Síndrome Metabólico |
|
dc.title |
Evaluation of 1-hour post load glucose levels, the metabolic syndrome and findrisc scores in the prediction of T2DM in patients with impaired fasting glucose |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.metabol.2023.155509 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.18 |
|
dc.relation.issn |
1532-8600 |
|